Attachment and Prognostic Factor: the Implicit Approach
AIA
Place of Attachment as a Post-weaning Prognostic Factor: Interest of the Implicit Approach
1 other identifier
observational
200
0 countries
N/A
Brief Summary
This is a prospective longitudinal study aimed at better understanding the determinants of the prognosis of patients with substance dependence. 5 visits are planned during the study :
- the inclusion visit : during this visit the patient's non-opposition is obtained and then the patient answer to self-administered questionnaires online
- 4 telephone interviews for follow-up by investigator.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 29, 2021
CompletedFirst Posted
Study publicly available on registry
July 8, 2021
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2028
Study Completion
Last participant's last visit for all outcomes
September 1, 2028
June 5, 2025
June 1, 2025
2 years
June 29, 2021
June 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Implicit attachment and onsumption
Assessment of the link between implicit attachment and changes in consumption after a 12-month follow-up
12 months
Study Arms (1)
Patients with a use-related disorder weaning for a substance
Interventions
5 visits are planned during the study : * the inclusion visit : during this visit the patient's non-opposition is obtained and then the patient answer to self-administered questionnaires online * 4 telephone interviews for follow-up by investigator
Eligibility Criteria
Patients with a use-related disorder weaning for a substance, supported within the addictology sector of Henri Laborit Hospital
You may qualify if:
- Patients between 18 and 65 years old
- Patients with a use-related disorder as defined by DSM5
- Patients weaning for a substance, supported within the addictology sector of Henri Laborit Hospital
- Having expressed non-opposition to participating in the study after receiving written information.
You may not qualify if:
- Person who cannot read or write
- Simultaneous participation in a therapeutic trial involving oxytocin
- Patients protected by law
- Patients who do not have French as their native language
- Patients who, in the opinion of the investigator, are unable to complete the questionnaires
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wilfried SERRA, Dr
Centre Hospitalier Henri Laborit
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 29, 2021
First Posted
July 8, 2021
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
September 1, 2028
Study Completion (Estimated)
September 1, 2028
Last Updated
June 5, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share